Literature DB >> 20160347

Organotypic specificity of key RET adaptor-docking sites in the pathogenesis of neurocristopathies and renal malformations in mice.

Sanjay Jain1, Amanda Knoten, Masato Hoshi, Hongtao Wang, Bhupinder Vohra, Robert O Heuckeroth, Jeffrey Milbrandt.   

Abstract

The receptor tyrosine kinase ret protooncogene (RET) is implicated in the pathogenesis of several diseases and in several developmental defects, particularly those in neural crest-derived structures and the genitourinary system. In order to further elucidate RET-mediated mechanisms that contribute to these diseases and decipher the basis for specificity in the pleiotropic effects of RET, we characterized development of the enteric and autonomic nervous systems in mice expressing RET9 or RET51 isoforms harboring mutations in tyrosine residues that act as docking sites for the adaptors Plcgamma, Src, Shc, and Grb2. Using this approach, we found that development of the genitourinary system and the enteric and autonomic nervous systems is dependent on distinct RET-stimulated signaling pathways. Thus, mutation of RET51 at Y1062, a docking site for multiple adaptor proteins including Shc, caused distal colon aganglionosis reminiscent of Hirschsprung disease (HSCR). On the other hand, this mutation in RET9, which encodes an isoform that lacks the Grb2 docking site present in RET51, produced severe abnormalities in multiple organs. Mutations that abrogate RET-Plcgamma binding, previously shown to produce features reminiscent of congenital anomalies of kidneys or urinary tract (CAKUT) syndrome, produced only minor abnormalities in the nervous system. Abrogating RET51-Src binding produced no major defects in these systems. These studies provide insight into the basis of organotypic specificity and redundancy in RET signaling within these unique systems and in diseases such as HSCR and CAKUT.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20160347      PMCID: PMC2827965          DOI: 10.1172/JCI41619

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

Review 1.  The phenotypes associated with ret mutations in the multiple endocrine neoplasia type 2 syndrome.

Authors:  B A Ponder
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

2.  Functional analysis of RET with Hirschsprung mutations affecting its kinase domain.

Authors:  T Iwashita; K Kurokawa; S Qiao; H Murakami; N Asai; K Kawai; M Hashimoto; T Watanabe; M Ichihara; M Takahashi
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

3.  CD44 is required for two consecutive steps in HGF/c-Met signaling.

Authors:  Véronique Orian-Rousseau; Linfeng Chen; Jonathan P Sleeman; Peter Herrlich; Helmut Ponta
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

4.  RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2.

Authors:  M J Lorenzo; G D Gish; C Houghton; T J Stonehouse; T Pawson; B A Ponder; D P Smith
Journal:  Oncogene       Date:  1997-02-20       Impact factor: 9.867

Review 5.  The MEN II syndromes and the role of the ret proto-oncogene.

Authors:  B A Ponder; D Smith
Journal:  Adv Cancer Res       Date:  1996       Impact factor: 6.242

Review 6.  The GDNF/RET signaling pathway and human diseases.

Authors:  M Takahashi
Journal:  Cytokine Growth Factor Rev       Date:  2001-12       Impact factor: 7.638

7.  Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction.

Authors:  M Albert Basson; Simge Akbulut; Judy Watson-Johnson; Ruth Simon; Thomas J Carroll; Reena Shakya; Isabelle Gross; Gail R Martin; Thomas Lufkin; Andrew P McMahon; Patricia D Wilson; Frank D Costantini; Ivor J Mason; Jonathan D Licht
Journal:  Dev Cell       Date:  2005-02       Impact factor: 12.270

Review 8.  The contribution of associated congenital anomalies in understanding Hirschsprung's disease.

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2006-03-04       Impact factor: 1.827

9.  Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret.

Authors:  A Schuchardt; V D'Agati; L Larsson-Blomberg; F Costantini; V Pachnis
Journal:  Nature       Date:  1994-01-27       Impact factor: 49.962

10.  Renal agenesis and hypodysplasia in ret-k- mutant mice result from defects in ureteric bud development.

Authors:  A Schuchardt; V D'Agati; V Pachnis; F Costantini
Journal:  Development       Date:  1996-06       Impact factor: 6.868

View more
  30 in total

Review 1.  Genetic interactions and modifier genes in Hirschsprung's disease.

Authors:  Adam S Wallace; Richard B Anderson
Journal:  World J Gastroenterol       Date:  2011-12-07       Impact factor: 5.742

2.  Traditional and targeted exome sequencing reveals common, rare and novel functional deleterious variants in RET-signaling complex in a cohort of living US patients with urinary tract malformations.

Authors:  Rajshekhar Chatterjee; Enrique Ramos; Mary Hoffman; Jessica VanWinkle; Daniel R Martin; Thomas K Davis; Masato Hoshi; Stanley P Hmiel; Anne Beck; Keith Hruska; Doug Coplen; Helen Liapis; Robi Mitra; Todd Druley; Paul Austin; Sanjay Jain
Journal:  Hum Genet       Date:  2012-06-23       Impact factor: 4.132

Review 3.  To bud or not to bud: the RET perspective in CAKUT.

Authors:  T Keefe Davis; Masato Hoshi; Sanjay Jain
Journal:  Pediatr Nephrol       Date:  2014-04       Impact factor: 3.714

Review 4.  Receptor tyrosine kinase signaling: regulating neural crest development one phosphate at a time.

Authors:  Katherine A Fantauzzo; Philippe Soriano
Journal:  Curr Top Dev Biol       Date:  2015-01-20       Impact factor: 4.897

Review 5.  Development and developmental disorders of the enteric nervous system.

Authors:  Florian Obermayr; Ryo Hotta; Hideki Enomoto; Heather M Young
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-12-11       Impact factor: 46.802

6.  Novel mechanisms of early upper and lower urinary tract patterning regulated by RetY1015 docking tyrosine in mice.

Authors:  Masato Hoshi; Ekatherina Batourina; Cathy Mendelsohn; Sanjay Jain
Journal:  Development       Date:  2012-05-23       Impact factor: 6.868

Review 7.  Renin-angiotensin system in ureteric bud branching morphogenesis: insights into the mechanisms.

Authors:  Ihor V Yosypiv
Journal:  Pediatr Nephrol       Date:  2011-02-26       Impact factor: 3.714

8.  MiR-195-5p inhibits proliferation and invasion of nerve cells in Hirschsprung disease by targeting GFRA4.

Authors:  Gang Wang; Hefeng Wang; Lijuan Zhang; Feng Guo; Xiangyu Wu; Yang Liu
Journal:  Mol Cell Biochem       Date:  2021-01-30       Impact factor: 3.396

Review 9.  Mammalian kidney development: principles, progress, and projections.

Authors:  Melissa H Little; Andrew P McMahon
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-05-01       Impact factor: 10.005

Review 10.  The developmental etiology and pathogenesis of Hirschsprung disease.

Authors:  Naomi E Butler Tjaden; Paul A Trainor
Journal:  Transl Res       Date:  2013-03-22       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.